Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ: 007370)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,090.00
-30.00 (-0.49%)
Dec 19, 2024, 1:07 PM KST
-0.16%
Market Cap 66.85B
Revenue (ttm) 111.15B
Net Income (ttm) 28.13B
Shares Out 11.43M
EPS (ttm) 2,160.83
PE Ratio 2.71
Forward PE n/a
Dividend 150.00 (2.56%)
Ex-Dividend Date Dec 27, 2024
Volume 75,856
Open 6,000.00
Previous Close 6,120.00
Day's Range 5,900.00 - 6,110.00
52-Week Range 4,860.00 - 8,100.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About Jin Yang Pharmaceutical

Jin Yang Pharmaceutical Co., Ltd. engages in the pharmaceutical business in South Korea. The company offers products for anti-diabetics, antivirals, anti-hypertensives, anti-coagulants, antihistamines, antipyretics, and analgesics; digestive, respiratory, and neuropsychiatric system. It also provides drugs for genito-urinary system, anti-osteoporosis drugs, antimicrobials and antibiotics; and over the counter drugs antipyretics and analgesics. It also provides products for digestive, genito-urinary, neuropsychiatric, circulatory, and dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1971
Employees 220
Stock Exchange KOSDAQ
Ticker Symbol 007370
Full Company Profile

Financial Performance

In 2023, Jin Yang Pharmaceutical's revenue was 94.11 billion, an increase of 23.40% compared to the previous year's 76.26 billion. Earnings were 12.66 billion, an increase of 2.85%.

Financial Statements

News

There is no news available yet.